Key result
Cholecystographic agent plus thionamide combination achieves 100% remission in amiodarone-induced thyrotoxicosis.
Why the study?
Effective and safe treatment options for type II amiodarone-induced hyperthyroidism in cardiac patients are needed.
Does a combination of an oral cholecystographic agent and a thionamide improve type II amiodarone-induced hyperthyroidism in cardiac patients?
Case Report (n=5)
Does a combination of an oral cholecystographic agent and a thionamide improve type II amiodarone-induced hyperthyroidism in cardiac patients?
A combination of an oral cholecystographic agent and a thionamide appears to be a safe and effective treatment for type II amiodarone-induced hyperthyroidism, often resulting in long-term hypothyroidism.
No takes yet. Share an insight, caveat, or question.
May rapidly control type II amiodarone-induced hyperthyroidism; hypothesis-generating and should not yet change practice.
CHOPRA et al. (2001) conducted a case report in Type II amiodarone-induced hyperthyroidism (n=5). Oral cholecystographic agent and a thionamide was evaluated on Clinical improvement and becoming euthyroid or hypothyroid. A combination of an oral cholecystographic agent and a thionamide resulted in clinical improvement and euthyroidism or hypothyroidism in all 5 patients within 15-31 weeks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: